How Much Did Deepcell Raise? Funding & Key Investors

Deepcell has successfully raised funds through five venture funding rounds, attracting a total of 11 investors. The company specializes in AI-powered single-cell classification and isolation, catering to various applications in life sciences.

Keep reading to explore the intricacies of Deepcell's fundraising journey and the investors backing this innovative platform.

What Is Deepcell?

Deepcell, based in Menlo Park, California, is a life science company specializing in AI-powered single-cell classification and isolation. The company operates in the fields of artificial intelligence, biotechnology, genetics, health care, and life sciences.

With a workforce of 101-250 employees, Deepcell leverages its REM-I platform to integrate imaging, deep learning, and gentle enrichment for single-cell morphology analysis. The company focuses on applications in oncology, drug discovery, cell and gene therapy, and other areas.

How Much Funding Has Deepcell Raised?

1. Series Unknown
   • Amount Raised: Not publicly disclosed
   • Date: April 2025
   • Lead Investors: Fifty Years
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To further develop and expand the company's AI-powered single-cell analysis platform.
2. Series B
   • Amount Raised: USD 73,000,000
   • Date: March 2022
   • Lead Investors: Koch Disruptive Technologies
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To accelerate the scaling of operations, continue product development, and enable early commercial introduction of Deepcell's AI-powered single-cell analysis platform.
3. Series A
   • Amount Raised: USD 20,000,000
   • Date: December 2020
   • Lead Investors: Bow Capital
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To support the development and commercialization of the company's single-cell analysis technology.
4. Seed
   • Amount Raised: Not publicly disclosed
   • Date: June 2019
   • Lead Investors: Not publicly disclosed
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To fund initial research and development efforts.
5. Seed
   • Amount Raised: USD 5,000,000
   • Date: December 2017
   • Lead Investors: Andreessen Horowitz
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To establish the company and develop its core technology.

Total Amount Raised: USD 98,000,000

Current Valuation: Not publicly disclosed

Key Investors

• Fifty Years
  • Details: Fifty Years is a venture capital firm that invests in companies solving the world's biggest problems. They focus on transformative technologies that can make a significant impact on society.
  • Investment Focus Areas: Biotechnology, Health Care, Artificial Intelligence
  • Notable Investments: Not publicly disclosed
• Koch Disruptive Technologies
  • Details: Koch Disruptive Technologies (KDT) is a subsidiary of Koch Industries focused on investing in high-growth companies that are innovating and transforming industries. They aim to support companies that can drive significant change.
  • Investment Focus Areas: Technology, Health Care, Disruptive Innovations
  • Notable Investments: Desktop Metal, InSightec, Kinsa
• Bow Capital
  • Details: Bow Capital is a venture capital firm that partners with visionary entrepreneurs. They invest in transformative technology companies that have the potential to create significant impact.
  • Investment Focus Areas: Technology, Health Care, High-Impact Sectors
  • Notable Investments: Fictiv, Vicarious, Rigetti Computing
• Andreessen Horowitz
  • Details: Andreessen Horowitz is a private venture capital firm known for its investments in technology companies. They support companies at various stages of growth, from early-stage startups to established businesses.
  • Investment Focus Areas: Technology, Health Care, Consumer Internet
  • Notable Investments: Facebook, Airbnb, Lyft
• Jeff Dean
  • Details: Jeff Dean is the Head of Google Brain, a deep learning artificial intelligence research team at Google. He is renowned for his contributions to AI and deep learning technologies.
  • Investment Focus Areas: AI, Deep Learning Technologies
  • Notable Investments: Not publicly disclosed

What's Next for Deepcell?

Deepcell stands at the cusp of significant growth, driven by the introduction of its "morpholomics" platform. This AI-powered technology offers unprecedented insights into single-cell morphology, opening doors to advancements in precision medicine, diagnostics, and therapeutic development. The recent $73 million Series B funding round underscores the vast potential of this platform, positioning Deepcell to scale operations and expand its market presence.

As the company transitions to late-stage development, future fundraising opportunities appear promising. The involvement of high-profile investors suggests continued financial support as Deepcell moves towards full commercialization. However, challenges such as ensuring scalability, maintaining cell viability, and navigating a competitive landscape remain. Overcoming these hurdles will be crucial for Deepcell to solidify its position as a leader in single-cell analysis.

Use Clay to Get Funding Data

Sales professionals, take advantage of Clay's platform to access comprehensive fundraising data on companies like Deepcell and gather other critical business insights.

Sign up for free to start leveraging these powerful tools today.